Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11372
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | He, Hong | en |
dc.contributor.author | Huynh, Nhi | en |
dc.contributor.author | Liu, Kevin H | en |
dc.contributor.author | Malcontenti-Wilson, Caterina | en |
dc.contributor.author | Zhu, Jin | en |
dc.contributor.author | Christophi, Christopher | en |
dc.contributor.author | Shulkes, Arthur | en |
dc.contributor.author | Baldwin, Graham S | en |
dc.date.accessioned | 2015-05-16T00:57:44Z | |
dc.date.available | 2015-05-16T00:57:44Z | |
dc.date.issued | 2011-11-15 | en |
dc.identifier.citation | Cancer Letters 2011; 317(1): 65-71 | en |
dc.identifier.govdoc | 22100495 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/11372 | en |
dc.description.abstract | The p21-activated kinase 1 (PAK1) plays important roles in cell growth, motility, and transformation. The aims of this study were to delineate the signalling mechanisms downstream of PAK1, and to investigate the importance of PAK1 for colorectal cancer (CRC) growth and metastasis in vivo. PAK1 knockdown in human CRC cell lines inhibited β-catenin expression, β-catenin/TCF4 transcriptional activity, and the expression of c-Myc. In mouse models PAK1 knockdown suppressed the growth and metastasis of human CRC cells by decreasing proliferation and increasing apoptosis. Our findings demonstrate for the first time the crucial role of PAK1 in CRC progression in vivo. | en |
dc.language.iso | en | en |
dc.subject.other | Animals | en |
dc.subject.other | Apoptosis | en |
dc.subject.other | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors.metabolism | en |
dc.subject.other | Cell Proliferation | en |
dc.subject.other | Colorectal Neoplasms.enzymology.genetics.pathology | en |
dc.subject.other | Gene Knockdown Techniques | en |
dc.subject.other | HCT116 Cells | en |
dc.subject.other | HT29 Cells | en |
dc.subject.other | Humans | en |
dc.subject.other | Liver Neoplasms.enzymology.genetics.secondary | en |
dc.subject.other | Mice | en |
dc.subject.other | Mice, SCID | en |
dc.subject.other | Neoplasm Invasiveness | en |
dc.subject.other | Proto-Oncogene Proteins c-myc.metabolism | en |
dc.subject.other | RNA Interference | en |
dc.subject.other | Signal Transduction | en |
dc.subject.other | Time Factors | en |
dc.subject.other | Transcription Factors.metabolism | en |
dc.subject.other | Transfection | en |
dc.subject.other | Tumor Burden | en |
dc.subject.other | Xenograft Model Antitumor Assays | en |
dc.subject.other | beta Catenin.genetics.metabolism | en |
dc.subject.other | p21-Activated Kinases.deficiency.genetics | en |
dc.title | P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Cancer letters | en |
dc.identifier.affiliation | Department of Surgery, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia 3084, Australia | en |
dc.identifier.doi | 10.1016/j.canlet.2011.11.014 | en |
dc.description.pages | 65-71 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/22100495 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Christophi, Christopher | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Surgery (University of Melbourne) | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Hepatopancreatobiliary Surgery | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.